Guaifenesin Tablet
FDA Label NDC 81993-002

14 label sections · Submitted to the FDA by Zennova Llc · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zennova Llc for the product Guaifenesin (NDC 81993-002). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredient (in each tablet), purpose, uses, warnings, ask a doctor before use if you have, stop use and ask a doctor if, when using this product, keep out of reach of children, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Stop Use And Ask A Doctor If

if cough lasts more than 7 days, please consult your physician or healthcare provider.

Keep Out Of Reach Of Children

In case of overdose, get medical help or contact a Poison Control Center (1-800-222-1222) right away.

If Pregnant Or Breast-Feeding

ask a health professional before use

* Please review the disclaimer below.